The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial

  • Hasnain M Dalal
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Rod S Taylor
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Kate Jolly
    Institute of Applied Health Research, University of Birmingham, Birmingham, UK
  • Russell C Davis
    Cardiology Department, Sandwell & West Birmingham Hospitals NHS Trust, Birmingham, UK
  • Patrick Doherty
    Department of Health Sciences, University of York, York, UK
  • Jackie Miles
    Research and Development, Aneurin Bevan University Health Board, St Woolos Hospital, Newport, UK
  • Robin van Lingen
    Duchy Hospital, Truro, UK
  • Fiona C Warren
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Colin Green
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Jennifer Wingham
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Colin Greaves
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Susannah Sadler
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Melvyn Hillsdon
    Sport and Health Sciences, University of Exeter, Exeter, UK
  • Charles Abraham
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Nicky Britten
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Julia Frost
    Institute of Health Research, University of Exeter Medical School, Exeter, UK
  • Sally Singh
    Centre for Exercise and Rehabilitation Science, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK
  • Christopher Hayward
    Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK
  • Victoria Eyre
    Re:Cognition Health, London, UK
  • Kevin Paul
    REACH-HF Patient and Public Involvement Group, c/o Research, Development & Innovation, Royal Cornwall Hospitals NHS Trust, Truro, UK
  • Chim C Lang
    School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK
  • Karen Smith
    School of Nursing and Health Sciences, University of Dundee, Dundee, UK

説明

<jats:sec><jats:title>Background</jats:title><jats:p>Cardiac rehabilitation improves health-related quality of life (HRQoL) and reduces hospitalizations in patients with heart failure, but international uptake of cardiac rehabilitation for heart failure remains low.</jats:p></jats:sec><jats:sec><jats:title>Design and methods</jats:title><jats:p>The aim of this multicentre randomized trial was to compare the REACH-HF (Rehabilitation EnAblement in CHronicHeart Failure) intervention, a facilitated self-care and home-based cardiac rehabilitation programme to usual care for adults with heart failure with reduced ejection fraction (HFrEF). The study primary hypothesis was that the addition of the REACH-HF intervention to usual care would improve disease-specific HRQoL (Minnesota Living with Heart Failure questionnaire (MLHFQ)) at 12 months compared with usual care alone.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The study recruited 216 participants, predominantly men (78%), with an average age of 70 years and mean left ventricular ejection fraction of 34%. Overall, 185 (86%) participants provided data for the primary outcome. At 12 months, there was a significant and clinically meaningful between-group difference in the MLHFQ score of –5.7 points (95% confidence interval –10.6 to –0.7) in favour of the REACH-HF intervention group ( p = 0.025). With the exception of patient self-care ( p < 0.001) there was no significant difference in other secondary outcomes, including clinical events ( p > 0.05) at follow-up compared with usual care. The mean cost of the REACH-HF intervention was £418 per participant.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The novel REACH-HF home-based facilitated intervention for HFrEF was clinically superior in disease-specific HRQoL at 12 months and offers an affordable alternative to traditional centre-based programmes to address current low cardiac rehabilitation uptake rates for heart failure.</jats:p></jats:sec>

収録刊行物

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ